Clinical Trial Update: Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing stereotactic radiotherapy for clear cell metastatic renal cell carcinoma in patients treated with sunitinib has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Metastatic Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Clear Cell Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED